rs372350326
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_024306.5(FA2H):c.443C>T(p.Pro148Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000274 in 1,461,758 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P148T) has been classified as Uncertain significance.
Frequency
Consequence
NM_024306.5 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary spastic paraplegia 35Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FA2H | NM_024306.5 | c.443C>T | p.Pro148Leu | missense_variant | Exon 3 of 7 | ENST00000219368.8 | NP_077282.3 | |
| FA2H | XM_011523317.4 | c.443C>T | p.Pro148Leu | missense_variant | Exon 3 of 6 | XP_011521619.1 | ||
| FA2H | XM_011523319.3 | c.203C>T | p.Pro68Leu | missense_variant | Exon 3 of 7 | XP_011521621.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FA2H | ENST00000219368.8 | c.443C>T | p.Pro148Leu | missense_variant | Exon 3 of 7 | 1 | NM_024306.5 | ENSP00000219368.3 | ||
| FA2H | ENST00000569949.1 | c.245C>T | p.Pro82Leu | missense_variant | Exon 3 of 5 | 4 | ENSP00000464576.1 | |||
| FA2H | ENST00000567683.5 | n.364-8147C>T | intron_variant | Intron 2 of 4 | 2 | ENSP00000455126.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251024 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.0000274 AC: 40AN: 1461758Hom.: 0 Cov.: 32 AF XY: 0.0000289 AC XY: 21AN XY: 727182 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 35 Pathogenic:2
- -
The missense c.443C>T (p.Pro148Leu) variant in FA2H gene has been reported previously in homozygous/ compound heterozygous states in multiple individuals affected with FA2H-related disorders (Dong et al., 2018; Shakya et al., 2019; Rattay et al., 2019; Powis et al., 2020). It has also been observed to segregate with disease in related individuals. The p.Pro148Leu variant is present with allele frequency of 0.0004% in gnomAD Exomes. This variant has been submitted to the ClinVar database as Pathogenic/ Likely Pathogenic. Multiple lines of computational evidence (Polyphen - Probably Damaging, SIFT - Damaging and MutationTaster - Disease causing) predict a damaging effect on protein structure and function for this variant. The reference amino acid at this position on FA2H is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The amino acid Pro at position 148 is changed to a Leu changing protein sequence and it might alter its composition and physico-chemical properties. Additional functional studies will be required to prove the pathogenicity of this variant. For these reasons, this variant has been classified as Likely Pathogenic. -
Spastic paraplegia Pathogenic:1
This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 148 of the FA2H protein (p.Pro148Leu). For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FA2H protein function. ClinVar contains an entry for this variant (Variation ID: 406877). This missense change has been observed in individual(s) with autosomal recessive hereditary spastic paraplegia (PMID: 29980238; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs372350326, gnomAD 0.003%). -
Neurodegeneration with brain iron accumulation Pathogenic:1
Variant summary: FA2H c.443C>T (p.Pro148Leu) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251024 control chromosomes. c.443C>T has been reported in the literature in at-least four individuals affected with early onset cerebellar ataxia, multifocal childhood onset dystonia and AR Hereditary spastic paraplegias (example, Shakya _2019, Powis_2020, Dong_2018). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 29980238, 31628766, 31429931). ClinVar contains an entry for this variant (Variation ID: 406877). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Inborn genetic diseases Pathogenic:1
- -
not provided Pathogenic:1
PP3, PM2, PM3, PS4_moderate -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at